US 10682310
Therapeutic compounds and formulations for intranasal delivery
granted A61KA61K31/417A61K31/5517
Quick answer
US patent 10682310 (Therapeutic compounds and formulations for intranasal delivery) held by Regents of the University of Minnesota expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/417, A61K31/5517, A61K38/4813, A61K38/482